You will only receive an alert if new information was published since you received one.
This topic page includes advice and information about the new coronavirus disease COVID-19 in Norway.
Here is a selection of key data and statistics about SARS-CoV-2 and COVID-19 disease in Norway.
Coronavirus - facts, advice and measures
Here you will find information about who should be in quarantine or isolation and how it should be carried out.
The government advises against all international travel that is not strictly necessary. There are also restrictions about entry to Norway.
People who have undergone COVID-19 are exempt from infection quarantine and waiting quarantine (but not entry quarantine) for 6 months after documenting a ...
People who have undergone COVID-19 are exempt from infection quarantine and waiting quarantine (but not entry quarantine...
Removed point about healthcare personnel who have been abroad from order of priority, according to test criteria
Updated "Only have up to 5 guests in private homes, gardens and cabins" (from 2 guests).
Updated according to the Government guidelines in effect from 16.04.2021
A growing number of studies and reports are being published on COVID-19 and the pandemic. This project will help decision makers and researchers navigate the research.
This page briefly describes the model used by the NIPH for situational awareness and forecasting of the coronavirus outbreak in Norway.
The national COVID-19 knowledge programme sends out a newsletter with the latest Norwegian research about COVID-19. You can find our methods as well as released newsletters below.
The register (Beredt C19) was established to give the NIPH an ongoing overview and knowledge of the prevalence, causal relationships and consequences of the COVID-19 epidemic in Norway.
A study about the role of children in the transmission of the new coronavirus (SARS CoV-2) in childcare centres, primary schools and secondary schools (1st to 10th grade).
The Corona Household Study will investigate the risk of infection, and immunity to, the novel coronavirus (SARS-CoV-2) among people living in the same household.